PWMG
LGND icon

Private Wealth Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Private Wealth Management Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2K Hold
10
– – ﹤0.01% 1087
2025
Q4 		$1.89K Hold
10
– – ﹤0.01% 1103
2025
Q3 		$1.77K Hold
10
– – ﹤0.01% 1148
2025
Q2 		$1.14K Hold
10
– – ﹤0.01% 1239
2025
Q1 		$1.05K Hold
10
– – ﹤0.01% 1252
2024
Q4 		$1.07K Hold
10
– – ﹤0.01% 1280
2024
Q3 		$1K Hold
10
– – ﹤0.01% 1282
2024
Q2 		$843 Hold
10
– – ﹤0.01% 1328
2024
Q1 		$731 Hold
10
– – ﹤0.01% 1366
2023
Q4 		$715 Buy
+10
New +$590 ﹤0.01% 1375

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

Private Wealth Management Group's LGND Position: Q1 2026 in Review

Private Wealth Management Group held its Ligand Pharmaceuticals (LGND) position steady in Q1 2026 at 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1087.

Private Wealth Management Group first reported a position in LGND in Q4 2023 and has held it in 10 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • Private Wealth Management Group held 10 shares of Ligand Pharmaceuticals worth $2K as of Q1 2026.
  • Private Wealth Management Group left its Ligand Pharmaceuticals share count unchanged in Q1 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q1 2026, its #1087 holding.
  • Private Wealth Management Group first reported a position in Ligand Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.